Share
Study finds PCOS and other menstrual disorders may be masked in these youth Girls diagnosed with type 2 diabetes have a high frequency of menstrual irregularities, according to a new study published in The Journal of Clinical Endocrinology & Metabolism. Menstrual irregularities can have a variety of causes, including pregnancy, hormonal imbalances, infections, diseases, trauma,...
Share
Link to fast food availability suggests environment may influence type 1 diabetes rates Hot spots of type 1 diabetes in New York City are found in food swamps, areas with a higher proportion of fast food restaurants, for children and adults with type 1 diabetes, according to a new study published in the Journal of...
Share
Canagliflozin improves renal outcomes in people with type 2 diabetes mellitus (T2DM) with or at high risk for cardiovascular (CV) disease, according to data recently presented at the 2018 National Kidney Foundation’s Spring Clinical Meetings in Austin, Texas.. This benefit was observed in people with both preserved and reduced kidney function, as measured by estimated...
Share
Alterations in the myocardial ghrelin-GHSR1a system may predict diabetic cardiomyopathy (DCM), according to a study recently published in the Journal of the Endocrine Society. Researchers led by Savita Dhanvantari, PhD, of the Lawson Health Research Institute in London, Ontario point out that DCM is characterized by progressive cardiac dysfunction, and that the early stages of...
Share
An international research group headed by scientists from Helmholtz Zentrum München has developed a method for calculating the risk for developing type-1 diabetes that is significantly superior to earlier methods. By analyzing up to 41 gene sites, it is possible to identify children at birth who are at least 25-times more likely to develop type...
Share
Ascensia Diabetes Care has revealed the six entries that will progress to the finalist stage of the Ascensia Diabetes Challenge, a global innovation competition that is seeking digital solutions to support type 2 diabetes management. The six finalists were selected from 116 submissions that were received and were chosen by a panel consisting of external...
Share
The MiniMed™ 670G insulin pump system (Medtronic, Northridge, California) can improve glycemic outcomes in children with type 1 diabetes as young as seven years of age, according to an industry-funded study. The results were presented at ENDO 2018, the 100th annual meeting of the Endocrine Society in Chicago, Ill. “The MiniMed™ 670G system can effectively...
Share
The U.S. Food and Drug Administration (FDA) has granted a De Novo request for the Dexcom G6® CGM System. The Dexcom G6 is indicated by the FDA for use as both a standalone CGM and for integration into automated insulin dosing (AID) systems. Along with this authorization, the FDA is establishing criteria, called special controls, which outline...
